| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $107.50 | $23.98 | 348.32% | 202.83x | 51.16x | 13.64x | 16.46x | 1.47x | $106.92M | 0.94% | $705.78M | 6.70 | $11.52B | 1,468.32 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $32.20 | $8.22 | 291.70% | 153.33x | 73.10x | 9.06x | 18.35x | 1.31x | $39.15M | 0.93% | $220.58M | 1.69 | $4.13B | 90.91 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $80.79 | $17.30 | 366.98% | 75.50x | 69.12x | 7.45x | 9.64x | 1.92x | $182.84M | 2.92% | $654.15M | 8.43 | $6.14B | 51.16 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $227.28 | $82.77 | 174.60% | 37.26x | 34.23x | 6.32x | 22.46x | 1.22x | $793.95M | 2.61% | $1.35B | 10.14 | $31.69B | 26.87 | ||
| HALO | HALOZYME THERAPEUTICS INC | $124.54 | $71.41 | 74.40% | 34.98x | 13.76x | 8.78x | 98.47x | 0.67x | $806.22M | 5.52% | $143.54M | 1.22 | $16.12B | 22.43 | ||
| VCEL | VERICEL CORP | $42.97 | $7.97 | 438.98% | 89.52x | 76.77x | 7.17x | 5.95x | 2.20x | $61.66M | 2.81% | $370.04M | 7.25 | $2.17B | 49.21 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $56.63 | $18.74 | 202.18% | 149.03x | 20.54x | 3.22x | 1.73x | 0.98x | $738.18M | 6.74% | $6.32B | 32.68 | $14.27B | 37.01 | ||
| RPRX | ROYALTY PHARMA PLC | $63.75 | $36.19 | 76.14% | 33.91x | 11.73x | 11.19x | 3.75x | 0.68x | $2.92B | 10.30% | $9.79B | 21.99 | $44.81B | 38.10 | ||
| KRYS | KRYSTAL BIOTECH INC | $320.13 | $83.14 | 285.06% | 38.71x | 41.64x | 21.46x | 6.97x | 2.10x | $257.78M | 2.73% | $1.36B | 46.03 | $9.06B | 38.82 | ||
| ADMA | ADMA BIOLOGICS INC | $10.95 | $6.96 | 57.37% | 15.21x | 13.76x | 4.88x | 6.01x | 0.89x | $116.47M | 4.66% | $408.21M | 1.79 | $2.51B | 10.79 | ||
| TGTX | TG THERAPEUTICS INC | $53.16 | $22.98 | 131.32% | 17.26x | 53.03x | 9.43x | 13.47x | 1.79x | $17.39M | 0.23% | $604.08M | 4.26 | $8.41B | 60.38 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.33 | $7.59 | 36.11% | 10.87x | 9.49x | 4.49x | 2.82x | 0.95x | $82.01M | 13.42% | $217.65M | 3.68 | $469.61M | 6.07 | ||
| MDXG | MIMEDX GROUP INC | $3.93 | $1.20 | 226.73% | 98.25x | -21.81x | 1.64x | 2.65x | 1.14x | $44.50M | 7.66% | $216.00M | 1.46 | $454.21M | 19.91 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $214.65 | $180.73 | 18.77% | 14.07x | 8.98x | 2.95x | 2.90x | 0.57x | $1.62B | 11.94% | $4.80B | 75.98 | $16.71B | 10.34 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $307.82 | $86.11 | 257.47% | 30.57x | 32.60x | 21.26x | 6.34x | 2.29x | $130.62M | 2.12% | $967.52M | 48.22 | $6.26B | 22.44 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $535.17 | $147.87 | 261.93% | 30.88x | 28.02x | 10.79x | 6.70x | 2.32x | $3.80B | 2.80% | $20.25B | 79.81 | $131.48B | 23.89 | ||
| EXEL | EXELIXIS INC | $65.31 | $30.53 | 113.93% | 19.85x | 19.61x | 6.72x | 8.78x | 1.25x | $1.17B | 7.16% | $1.84B | 7.35 | $16.07B | 14.77 | ||
| UTHR | UNITED THERAPEUTICS CORP | $584.79 | $187.97 | 211.10% | 19.34x | 21.63x | 7.90x | 3.92x | 3.56x | $1.09B | 4.39% | $6.40B | 150.24 | $23.28B | 13.89 | ||
| TECH | BIO-TECHNE CORP | $72.62 | $16.27 | 346.43% | 62.07x | 34.95x | 9.32x | 5.40x | 1.97x | $263.22M | 2.32% | $2.11B | 13.52 | $11.41B | 32.83 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.03 | $30.76 | 17.13% | 11.47x | 8.64x | 2.17x | 2.10x | 0.65x | $354.90M | 17.00% | $999.24M | 17.25 | $1.70B | 6.08 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $819.09 | $428.28 | 91.25% | 19.53x | 14.02x | 5.42x | 2.66x | 1.03x | $3.76B | 4.47% | $31.71B | 308.48 | $84.58B | 14.71 | ||
| VCYT | VERACYTE INC | $46.04 | $11.88 | 287.48% | 31.97x | 23.68x | 6.55x | 2.67x | 2.59x | $165.99M | 4.51% | $1.39B | 17.36 | $3.44B | 24.63 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.13 | $1.38 | -18.36% | 8.07x | -2.55x | 1.39x | 1.49x | 0.45x | $19.58M | 29.91% | $44.20M | 0.76 | $17.07M | 2.23 | ||
| INCY | INCYTE CORP | $116.93 | $57.46 | 103.49% | 14.40x | 34.78x | 4.03x | 3.74x | 1.72x | $1.92B | 8.20% | $6.34B | 31.66 | $19.75B | 9.55 |